» Articles » PMID: 31106110

A Study of the Prebiotic Effect of Lactulose at Low Dosages in Healthy Japanese Women

Overview
Specialty Biology
Date 2019 May 21
PMID 31106110
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

To investigate the prebiotic effect of lactulose at low dosages, we assessed changes in defaecation frequency following ingestion of 1, 2, or 3 g/day of lactulose for 2 weeks. Each test was carried out after a 2-week washout period. This was an open-label, before-after trial that enrolled 26 healthy Japanese women. The defaecation frequency, number of defaecation days, and number of faecal bifidobacteria increased significantly compared with before ingestion of 1, 2, and 3 g/day of lactulose. These results suggest that even 1 g/day of lactulose could have a prebiotic effect.

Citing Articles

Effects of a prebiotic formulation on the composition of the faecal microbiota of people with functional constipation.

Erhardt R, Steels E, Harnett J, Taing M, Steadman K Eur J Nutr. 2024; 63(3):777-784.

PMID: 38165420 DOI: 10.1007/s00394-023-03292-9.


Functional constipation and the effect of prebiotics on the gut microbiota: a review.

Erhardt R, Harnett J, Steels E, Steadman K Br J Nutr. 2022; 130(6):1015-1023.

PMID: 36458339 PMC: 10442792. DOI: 10.1017/S0007114522003853.


The potential role of lactulose pharmacotherapy in the treatment and prevention of diabetes.

Chu N, Ling J, Jie H, Leung K, Poon E Front Endocrinol (Lausanne). 2022; 13:956203.

PMID: 36187096 PMC: 9519995. DOI: 10.3389/fendo.2022.956203.


Lactulose Ingestion Induces a Rapid Increase in Genus in Healthy Japanese: A Randomised, Double-Blind, Placebo-Controlled Crossover Trial.

Sakai Y, Ochi H, Tanaka M Microorganisms. 2022; 10(9).

PMID: 36144321 PMC: 9506086. DOI: 10.3390/microorganisms10091719.


Low-Dose Lactulose as a Prebiotic for Improved Gut Health and Enhanced Mineral Absorption.

Karakan T, Tuohy K, Janssen-van Solingen G Front Nutr. 2021; 8:672925.

PMID: 34386514 PMC: 8353095. DOI: 10.3389/fnut.2021.672925.


References
1.
PETUELY F . [Lactobacillus bifidus flora produced in artificially-fed infants by bifidogenic substances (bifidus factor)]. Z Kinderheilkd. 1957; 79(2):174-9. View

2.
Matsuki T, Watanabe K, Fujimoto J, Kado Y, Takada T, Matsumoto K . Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria. Appl Environ Microbiol. 2004; 70(1):167-73. PMC: 321263. DOI: 10.1128/AEM.70.1.167-173.2004. View

3.
Bouhnik Y, Attar A, Joly F, Riottot M, Dyard F, Flourie B . Lactulose ingestion increases faecal bifidobacterial counts: a randomised double-blind study in healthy humans. Eur J Clin Nutr. 2004; 58(3):462-6. DOI: 10.1038/sj.ejcn.1601829. View

4.
Vanhoutte T, De Preter V, De Brandt E, Verbeke K, Swings J, Huys G . Molecular monitoring of the fecal microbiota of healthy human subjects during administration of lactulose and Saccharomyces boulardii. Appl Environ Microbiol. 2006; 72(9):5990-7. PMC: 1563651. DOI: 10.1128/AEM.00233-06. View

5.
Satoh T, Odamaki T, Namura M, Shimizu T, Iwatsuki K, Nishimoto M . In vitro comparative evaluation of the impact of lacto-N-biose I, a major building block of human milk oligosaccharides, on the fecal microbiota of infants. Anaerobe. 2012; 19:50-7. DOI: 10.1016/j.anaerobe.2012.12.007. View